贲门腺癌术中综合治疗对其预后的影响
2014-10-21何志德
何志德
【摘 要】目的:探讨贲门腺癌术中综合治疗对患者预后的影响。方法:将中晚期患者随机分为常规治疗A组(单纯行根治术)和实验治疗B组(在根治手术同时行术中全身化疗、癌床局部化疗及胸腹腔温热化疗IPHC)两组,观察其并发症的发生率、复发转移率、生存率的差别。结果:两组术后并发症发生率无明显差异(p>0.05),实验组3年生存率远高于常规治疗组(p<0.01),而复发转移率明显低于常规治疗组(p<0.01)。结论:贲门腺癌术中综合治疗对预后有重要意义,明显降低术中复发率,可提高患者生存率。
【关键词】贲门腺癌;手术/局部化疗;腹腔灌注;预后
【文章编号】1004-7484(2014)06-3467-02
The influence on prognosis of combined therapy for adenocarcinoma of gastric cardia.
He zhide.
The health center of laixi wubei,shandong,china.
【Abstract】Objective:Investigate the influence on prognosis of combined therapy for adenocarcinoma of gastric cardia. Methods:To divide the advanced stage patients randomly into two groups A and B.To practise radical correction purely in group A and practise radical correction accompanied with intraoperative chemotherapy, partial chemotherapy of tumor surrounding and IPHC of thoracic and abdominal cavity in group B. To observe the differences of incidence rate relapse and metastasis rate and survival rate between the to groups. Results:The difference of incidence rate of complication between them is not significant (p>0.05).The survival rate of group B is much higher than that of group A (p<0.01) while the relapse and metastasis rate is much lower (p<0.01).Conclusion:The combined therapy for adenocarcinoma of gastric cardia is greatly recommended in prognosis. It markedly reduces the relapse and metastasis rate and incerases the survival rate of the patients after therapy.
【Key words】Adenocarcinoma of gastric cardia; Operation, Systemic/partial chemotherapy; abdominal cavity perfusion; Influence
賁门腺癌是常见的恶性肿瘤,其恶性程度高,血行播散及淋巴结转移早。手术效果常不理想。我们采用术中综合治疗方法,研究对贲门癌预后的影响,并对以手术为主贲门癌的综合治疗进行评价。
1 资料与方法
1.1 一般资料 2009年1月~2013年6月共施行贲门腺癌手术62例,手术切除52例,切除率83.9%。将可切除的贲门癌患者随机分为常规治疗组和实验组两组,常规治疗组(单纯手术治疗)27例,男性21例,女性6例,年龄51.2±7岁;实验组(术中综合治疗)25例,男性19例,女性6例,年龄51.4±8.5岁。
1.2 病理类型和病理分期 52例中,高、中、低分化腺癌44例,粘液腺癌6例,印戒细胞癌2例。病理分期:常规治疗组:Ⅰ期1例,Ⅱ期7例,Ⅲ期19例。实验组:Ⅰ期1例,Ⅱ期6例,Ⅲ期18例。有淋巴结转移:常规治疗组15例(56%);实验组16例(64%)。
1.3 术式及切除范围 经胸、膈或胸腹联合切扣,施行近胃切除、食管胃吻合或全胃切除、食管-空肠吻合术。清扫食管下段旁、贲门旁、胃小弯侧、胃左动脉旁、脾门旁、腹腔动脉旁、幽门旁淋巴结。全组切缘无癌细胞残留。
1.4 术中综合治疗方法 术中确定肿瘤能切除后,即应用0.9%NS60ml+MMC20mg静脉推注。切除……
